Capital Clean Energy Carriers Corp. (CCEC)
NASDAQ: CCEC · Real-Time Price · USD
23.00
-0.79 (-3.32%)
Aug 11, 2025, 4:00 PM - Market closed
Revance Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 424.7 | 369.41 | 241.77 | 187.25 | 184.67 | 140.87 | Upgrade | |
Revenue Growth (YoY) | 84.28% | 52.80% | 29.11% | 1.40% | 31.09% | 29.98% | Upgrade |
Cost of Revenue | 78.93 | 75.45 | 60.72 | 48.99 | 57.82 | 45.02 | Upgrade |
Gross Profit | 345.77 | 293.96 | 181.05 | 138.26 | 126.85 | 95.84 | Upgrade |
Selling, General & Admin | 17 | 16.68 | 13.45 | 10.68 | 8.66 | 7.2 | Upgrade |
Operating Expenses | 113.77 | 102.84 | 68.31 | 51.72 | 55.6 | 48.6 | Upgrade |
Operating Income | 232 | 191.13 | 112.74 | 86.54 | 71.25 | 47.24 | Upgrade |
Interest Expense | -131.27 | -134.75 | -93.51 | -44.05 | -16.59 | -16.74 | Upgrade |
Currency Exchange Gain (Loss) | 37.92 | -4.54 | 1.31 | -14.81 | -3.54 | - | Upgrade |
Other Non Operating Income (Expenses) | -39.23 | 2.78 | -2.29 | 11.37 | 0.25 | -0.14 | Upgrade |
EBT Excluding Unusual Items | 99.42 | 54.61 | 18.25 | 39.05 | 51.37 | 30.37 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 47.28 | 46.81 | - | Upgrade |
Asset Writedown | - | - | -11.16 | - | - | - | Upgrade |
Pretax Income | 99.42 | 54.61 | 7.09 | 86.33 | 98.18 | 30.37 | Upgrade |
Earnings From Continuing Operations | 99.42 | 54.61 | 7.09 | 86.33 | 98.18 | 30.37 | Upgrade |
Earnings From Discontinued Operations | 136.62 | 139.03 | 40.12 | 39.09 | - | - | Upgrade |
Net Income to Company | 236.04 | 193.63 | 47.21 | 125.42 | 98.18 | 30.37 | Upgrade |
Minority Interest in Earnings | -0.32 | -0.74 | -0.68 | -2.16 | -1.79 | -0.56 | Upgrade |
Net Income | 235.72 | 192.89 | 46.53 | 123.26 | 96.39 | 29.81 | Upgrade |
Preferred Dividends & Other Adjustments | 0.81 | 0.81 | 0.93 | 3.66 | 2.05 | 0.69 | Upgrade |
Net Income to Common | 234.91 | 192.08 | 45.6 | 119.6 | 94.34 | 29.12 | Upgrade |
Net Income Growth | 142.92% | 314.57% | -62.25% | 27.88% | 223.35% | - | Upgrade |
Shares Outstanding (Basic) | 58 | 56 | 21 | 19 | 18 | 18 | Upgrade |
Shares Outstanding (Diluted) | 58 | 56 | 21 | 19 | 18 | 18 | Upgrade |
Shares Change (YoY) | 49.60% | 164.82% | 9.61% | 5.36% | 0.81% | 0.09% | Upgrade |
EPS (Basic) | 4.05 | 3.42 | 2.15 | 6.19 | 5.14 | 1.60 | Upgrade |
EPS (Diluted) | 4.05 | 3.42 | 2.15 | 6.19 | 5.14 | 1.60 | Upgrade |
EPS Growth | 62.67% | 59.07% | -65.22% | 20.34% | 221.29% | - | Upgrade |
Free Cash Flow | 56.61 | -960.68 | -262.22 | 32.79 | -256.93 | -104.57 | Upgrade |
Free Cash Flow Per Share | 0.98 | -17.13 | -12.38 | 1.70 | -14.01 | -5.75 | Upgrade |
Dividend Per Share | 0.600 | 0.600 | 0.600 | 0.600 | 0.450 | 0.650 | Upgrade |
Dividend Growth | 100.00% | - | - | 33.33% | -30.77% | -49.81% | Upgrade |
Gross Margin | 81.42% | 79.58% | 74.89% | 73.84% | 68.69% | 68.04% | Upgrade |
Operating Margin | 54.63% | 51.74% | 46.63% | 46.22% | 38.58% | 33.54% | Upgrade |
Profit Margin | 55.31% | 52.00% | 18.86% | 63.87% | 51.08% | 20.67% | Upgrade |
Free Cash Flow Margin | 13.33% | -260.06% | -108.46% | 17.51% | -139.13% | -74.23% | Upgrade |
EBITDA | 348.31 | 293.15 | 162.96 | 134.05 | 125.47 | 100.34 | Upgrade |
EBITDA Margin | 82.01% | 79.35% | 67.40% | 71.59% | 67.94% | 71.23% | Upgrade |
D&A For EBITDA | 116.31 | 102.02 | 50.22 | 47.52 | 54.22 | 53.1 | Upgrade |
EBIT | 232 | 191.13 | 112.74 | 86.54 | 71.25 | 47.24 | Upgrade |
EBIT Margin | 54.63% | 51.74% | 46.63% | 46.22% | 38.58% | 33.54% | Upgrade |
Updated May 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.